SCHEMBL21392869

SCHEMBL21392869

C=CC(=O)n1ccc2ccc(C(C)C)cc21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 1/20 0.37
EIF4A3 P38919 1/20 0.36
ACHE P22303 3/20 0.35
NOTUM Q6P988 1/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 4/20 0.35
KDM4E B2RXH2 4/20 0.35
HSD17B10 Q99714 3/20 0.35
TP53 P04637 2/20 0.35
TYR P14679 1/20 0.34
ALOX12 P18054 2/20 0.33
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
HIF1A Q16665 1/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
OXER1 Q8TDS5 1/20 0.33
POLB P06746 1/20 0.32
APOBEC3A P31941 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
RNASEH1 O60930 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21401774 0.88 TYR (0.37) EIF4A3ACHENOTUMALDH1A1TYR
SCHEMBL28403547 0.77 ACHE (0.38) ACHENOTUMALDH1A1HPGDKDM4E
SCHEMBL20905149 0.77 TFPI2 (0.50) ACHEKDM4EMEN1KMT2A
SCHEMBL31565005 0.73 NOTUM (0.59) NOTUMALDH1A1HPGDKDM4EHSD17B10
SCHEMBL10835083 0.73 NOTUM (0.59) NOTUMALDH1A1HPGDKDM4EHSD17B10
SCHEMBL23612479 0.71 NPC1 (0.47) HTR7ALDH1A1HTTSMN1; SMN2MAPT
SCHEMBL21392786 0.70 OXER1 (0.39) ALDH1A1SMN1; SMN2OXER1POLBMEN1
SCHEMBL17785763 0.69 OXER1 (0.38) NOTUMALDH1A1HPGDKDM4EHSD17B10
SCHEMBL22515890 0.69 NOTUM (0.54) EIF4A3NOTUMALDH1A1HPGDKDM4E
SCHEMBL20905230 0.69 AKR1C3 (0.38) ACHENOTUMOXER1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-11666661-B2 Methods and compounds for targeted autophagy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-06 US disclosed
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY FRONTIER MEDICINES CORPORATION 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190290778-A1 METHODS AND COMPOUNDS FOR TARGETED AUTOPHAGY ATG7, BECN1, SQSTM1 HTR7 1756/4885EIF4A3 987/4885ACHE 4822/4885
US-11666661-B2 Methods and compounds for targeted autophagy ATG7, BECN1, SQSTM1 HTR7 1756/4885EIF4A3 987/4885ACHE 4822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.